Through ongoing monitoring and adjustments, we guarantee your program evolves with your progress
tirzepatide (LY3298176, picture from literature: PMID-31686879) SURPASS-4 is an open-label global trial, in 2002 cases of increased cardiovascular (CV) risk, have received 1-3 oral hypoglycemic drugs (metformin, sulfonylurea, SGLT2 inhibitors) treatment but blood sugar levels are controlled It was carried out in adults with poor type 2 diabetes, and the efficacy and safety of three doses of tirzepatide (5mg, 10mg, 15mg) and titrated insulin glargine were evaluated
Kurhaluk N, Kamiski P, Bilski R, Koodziejska R, Woniak A, Tkaczenko H
Guidance from UK anaesthetic bodies, including the Association of Anaesthetists and the Centre for Perioperative Care (CPOC) , emphasises the importance of discussing GLP-1 medications with your surgical team well in advance of any planned procedure
Do not transfer to other containers